551 related articles for article (PubMed ID: 32698040)
1. Cholesterol metabolism: New functions and therapeutic approaches in cancer.
Xu H; Zhou S; Tang Q; Xia H; Bi F
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188394. PubMed ID: 32698040
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways: sterols and receptor signaling in cancer.
Gabitova L; Gorin A; Astsaturov I
Clin Cancer Res; 2014 Jan; 20(1):28-34. PubMed ID: 24158702
[TBL] [Abstract][Full Text] [Related]
3. The Role of Oxysterols in Human Cancer.
Kloudova A; Guengerich FP; Soucek P
Trends Endocrinol Metab; 2017 Jul; 28(7):485-496. PubMed ID: 28410994
[TBL] [Abstract][Full Text] [Related]
4. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer.
Snaebjornsson MT; Janaki-Raman S; Schulze A
Cell Metab; 2020 Jan; 31(1):62-76. PubMed ID: 31813823
[TBL] [Abstract][Full Text] [Related]
5. Even Cancer Cells Watch Their Cholesterol!
Riscal R; Skuli N; Simon MC
Mol Cell; 2019 Oct; 76(2):220-231. PubMed ID: 31586545
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
7. Emerging mechanisms and targeted therapy of ferroptosis in cancer.
Wang H; Cheng Y; Mao C; Liu S; Xiao D; Huang J; Tao Y
Mol Ther; 2021 Jul; 29(7):2185-2208. PubMed ID: 33794363
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
9. RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases.
Zou H; Yang N; Zhang X; Chen HW
Biochem Pharmacol; 2022 Feb; 196():114725. PubMed ID: 34384758
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.
Huang B; Song BL; Xu C
Nat Metab; 2020 Feb; 2(2):132-141. PubMed ID: 32694690
[TBL] [Abstract][Full Text] [Related]
12. Targeting dysregulated lipid metabolism in the tumor microenvironment.
Kim DH; Song NY; Yim H
Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cell Metabolism as Cancer Therapy.
Ngoi NYL; Eu JQ; Hirpara J; Wang L; Lim JSJ; Lee SC; Lim YC; Pervaiz S; Goh BC; Wong ALA
Antioxid Redox Signal; 2020 Feb; 32(5):285-308. PubMed ID: 31841375
[No Abstract] [Full Text] [Related]
14. [Ferroptosis, a new form of cell death relevant to the medical treatment of cancer].
Lachaier E; Louandre C; Ezzoukhry Z; Godin C; Mazière JC; Chauffert B; Galmiche A
Med Sci (Paris); 2014; 30(8-9):779-83. PubMed ID: 25174755
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.
Vernieri C; Casola S; Foiani M; Pietrantonio F; de Braud F; Longo V
Cancer Discov; 2016 Dec; 6(12):1315-1333. PubMed ID: 27872127
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
Liang C; Zhang X; Yang M; Dong X
Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Hallmarks of Cancer Metabolism.
Pavlova NN; Thompson CB
Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol metabolism: At the cross road between cancer cells and immune environment.
Kopecka J; Godel M; Riganti C
Int J Biochem Cell Biol; 2020 Dec; 129():105876. PubMed ID: 33166677
[TBL] [Abstract][Full Text] [Related]
19. Targeting metabolic dependencies in pediatric cancer.
Issaq SH; Heske CM
Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
[TBL] [Abstract][Full Text] [Related]
20. Targeting Ferroptosis to Iron Out Cancer.
Hassannia B; Vandenabeele P; Vanden Berghe T
Cancer Cell; 2019 Jun; 35(6):830-849. PubMed ID: 31105042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
